Drug-eluting versus third-generation bare metal stents: The US strategy

Daniel W. Isenbarger; Jon R. Resar

doi:10.1080/14628840500434958

Drug-eluting versus third-generation bare metal stents: The US strategy

Daniel W. Isenbarger, Jon R. Resar

School of Medicine

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

Drug-eluting stents have rapidly come to dominate the field of coronary intervention, constituting 85% of the US market just one year after introduction. The current utilization of bare metal stents in coronary intervention in the US is quite limited. This article will review technological advances in third-generation bare metal stents, which optimize procedural performance by means of improved flexibility, lower crossing profile, and thinner struts while maintaining fluoroscopic visibility and may portend a continued role for bare metal stents in some settings. This article will review data pertaining to outcomes with new generation bare metal stents and discuss current options for utilization of drug eluting stents versus bare metal stents in the US.

Original language	English (US)
Pages (from-to)	171-175
Number of pages	5
Journal	International Journal of Cardiovascular Interventions
Volume	7
Issue number	4
DOIs	https://doi.org/10.1080/14628840500434958
State	Published - Dec 1 2005

Keywords

Bare metal stents
Coronary intervention
Drug-eluting stents

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1080/14628840500434958

Cite this

@article{dc617a705c3e4f6ba38add5fca897ae9,

title = "Drug-eluting versus third-generation bare metal stents: The US strategy",

abstract = "Drug-eluting stents have rapidly come to dominate the field of coronary intervention, constituting 85% of the US market just one year after introduction. The current utilization of bare metal stents in coronary intervention in the US is quite limited. This article will review technological advances in third-generation bare metal stents, which optimize procedural performance by means of improved flexibility, lower crossing profile, and thinner struts while maintaining fluoroscopic visibility and may portend a continued role for bare metal stents in some settings. This article will review data pertaining to outcomes with new generation bare metal stents and discuss current options for utilization of drug eluting stents versus bare metal stents in the US.",

keywords = "Bare metal stents, Coronary intervention, Drug-eluting stents",

author = "Isenbarger, {Daniel W.} and Resar, {Jon R.}",

year = "2005",

month = dec,

day = "1",

doi = "10.1080/14628840500434958",

language = "English (US)",

volume = "7",

pages = "171--175",

journal = "International Journal of Cardiovascular Interventions",

issn = "1462-8848",

publisher = "Taylor and Francis Ltd.",

number = "4",

}

TY - JOUR

T1 - Drug-eluting versus third-generation bare metal stents

T2 - The US strategy

AU - Isenbarger, Daniel W.

AU - Resar, Jon R.

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Drug-eluting stents have rapidly come to dominate the field of coronary intervention, constituting 85% of the US market just one year after introduction. The current utilization of bare metal stents in coronary intervention in the US is quite limited. This article will review technological advances in third-generation bare metal stents, which optimize procedural performance by means of improved flexibility, lower crossing profile, and thinner struts while maintaining fluoroscopic visibility and may portend a continued role for bare metal stents in some settings. This article will review data pertaining to outcomes with new generation bare metal stents and discuss current options for utilization of drug eluting stents versus bare metal stents in the US.

AB - Drug-eluting stents have rapidly come to dominate the field of coronary intervention, constituting 85% of the US market just one year after introduction. The current utilization of bare metal stents in coronary intervention in the US is quite limited. This article will review technological advances in third-generation bare metal stents, which optimize procedural performance by means of improved flexibility, lower crossing profile, and thinner struts while maintaining fluoroscopic visibility and may portend a continued role for bare metal stents in some settings. This article will review data pertaining to outcomes with new generation bare metal stents and discuss current options for utilization of drug eluting stents versus bare metal stents in the US.

KW - Bare metal stents

KW - Coronary intervention

KW - Drug-eluting stents

UR - http://www.scopus.com/inward/record.url?scp=29744436601&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29744436601&partnerID=8YFLogxK

U2 - 10.1080/14628840500434958

DO - 10.1080/14628840500434958

M3 - Review article

C2 - 16373262

AN - SCOPUS:29744436601

SN - 1462-8848

VL - 7

SP - 171

EP - 175

JO - International Journal of Cardiovascular Interventions

JF - International Journal of Cardiovascular Interventions

IS - 4

ER -

Drug-eluting versus third-generation bare metal stents: The US strategy

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this